Dennis Timko
Foot & Ankle Surgery · Eureka, MONPI 1013931815
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Elite Orthopedics, LLC accounts for 60.6% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $1,855 and has fallen 91.3% since, to $162 in 2025.
Across 108 payments — averaging $51.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$3K
- Zimmer Biomet$736
- Paratek Pharmaceuticals, Inc.$297
- Zyla Life Sciences, Inc.$194
- Tactile Systems Technology Inc$135
- Cook Medical LLC$91
- plus $740 from 25 others
What the payments were for
- Travel & lodging$3396%
- Food & beverage$1,94735%
- Education$3,27959%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 8 | $3,372 |
| Zimmer Biomet | 16 | $736 |
| Paratek Pharmaceuticals, Inc. | 16 | $297 |
| Zyla Life Sciences, Inc. | 23 | $194 |
| Tactile Systems Technology Inc | 5 | $135 |
| Cook Medical LLC | 1 | $91 |
| Medtronic | 4 | $81 |
| Organogenesis Inc. | 5 | $79 |
| Vaporox, Inc. | 1 | $69 |
| AbbVie | 2 | $57 |
| AstraZeneca | 2 | $49 |
| Kerecis Limited | 3 | $43 |
| Stryker | 2 | $43 |
| Amgen | 2 | $32 |
| Exact Sciences | 2 | $28 |
| Xtant Medical Inc | 1 | $27 |
| Averitas Pharma Inc. | 1 | $22 |
| UCB, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Solventum Corporation | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Lifenet Health | 1 | $15 |
| Biocomposites Inc | 1 | $14 |
| Smith+Nephew | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $14 |
| Merck | 1 | $14 |
| Abbott | 1 | $13 |
| Arteriocyte Medical Systems, Inc. | 1 | $13 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
| Integra Lifesciences Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,565 in reported general payments places this provider in the 55th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 35 | $533 |
| Mupirocin | 49 | $388 |
| Ketoconazole | 14 | $151 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Eureka
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Timothy BadweyKansas City$427K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- Amar PatelLees Summit$203K
- Anthony LombardoBridgeton$132K
- Jason AndersonKansas City$131K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.